BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32092396)

  • 1. Natural-product-library-based screening for discovery of capsid C-terminal domain targeted HIV-1 inhibitors.
    Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Zheng YT; Luo H
    Int J Antimicrob Agents; 2020 Apr; 55(4):105926. PubMed ID: 32092396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A HTRF based competitive binding assay for screening specific inhibitors of HIV-1 capsid assembly targeting the C-Terminal domain of capsid.
    Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Bedwell GJ; Engelman AN; Zheng YT; Chang S
    Antiviral Res; 2019 Sep; 169():104544. PubMed ID: 31254557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication.
    Thenin-Houssier S; de Vera IM; Pedro-Rosa L; Brady A; Richard A; Konnick B; Opp S; Buffone C; Fuhrmann J; Kota S; Billack B; Pietka-Ottlik M; Tellinghuisen T; Choe H; Spicer T; Scampavia L; Diaz-Griffero F; Kojetin DJ; Valente ST
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2195-208. PubMed ID: 26810656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein.
    Lemke CT; Titolo S; von Schwedler U; Goudreau N; Mercier JF; Wardrop E; Faucher AM; Coulombe R; Banik SS; Fader L; Gagnon A; Kawai SH; Rancourt J; Tremblay M; Yoakim C; Simoneau B; Archambault J; Sundquist WI; Mason SW
    J Virol; 2012 Jun; 86(12):6643-55. PubMed ID: 22496222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The capsid protein of human immunodeficiency virus: designing inhibitors of capsid assembly.
    Neira JL
    FEBS J; 2009 Nov; 276(21):6110-7. PubMed ID: 19825045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific Inhibitors of HIV Capsid Assembly Binding to the C-Terminal Domain of the Capsid Protein: Evaluation of 2-Arylquinazolines as Potential Antiviral Compounds.
    Machara A; Lux V; Kožíšek M; Grantz Šašková K; Štěpánek O; Kotora M; Parkan K; Pávová M; Glass B; Sehr P; Lewis J; Müller B; Kräusslich HG; Konvalinka J
    J Med Chem; 2016 Jan; 59(2):545-58. PubMed ID: 26685880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain.
    Zhang H; Curreli F; Zhang X; Bhattacharya S; Waheed AA; Cooper A; Cowburn D; Freed EO; Debnath AK
    Retrovirology; 2011 May; 8():28. PubMed ID: 21539734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Maturation: Lessons Learned from Inhibitors.
    Kleinpeter AB; Freed EO
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32858867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
    Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
    J Virol; 2017 May; 91(9):. PubMed ID: 28202766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendrimers as potential inhibitors of the dimerization of the capsid protein of HIV-1.
    Doménech R; Abian O; Bocanegra R; Correa J; Sousa-Herves A; Riguera R; Mateu MG; Fernandez-Megia E; Velázquez-Campoy A; Neira JL
    Biomacromolecules; 2010 Aug; 11(8):2069-78. PubMed ID: 20690715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid.
    Li J; Tan Z; Tang S; Hewlett I; Pang R; He M; He S; Tian B; Chen K; Yang M
    Bioorg Med Chem; 2009 Apr; 17(8):3177-88. PubMed ID: 19328002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PF74 Inhibits HIV-1 Integration by Altering the Composition of the Preintegration Complex.
    Balasubramaniam M; Zhou J; Addai A; Martinez P; Pandhare J; Aiken C; Dash C
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.
    Shi J; Zhou J; Shah VB; Aiken C; Whitby K
    J Virol; 2011 Jan; 85(1):542-9. PubMed ID: 20962083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity.
    Bocanegra R; Nevot M; Doménech R; López I; Abián O; Rodríguez-Huete A; Cavasotto CN; Velázquez-Campoy A; Gómez J; Martínez MÁ; Neira JL; Mateu MG
    PLoS One; 2011; 6(9):e23877. PubMed ID: 21931621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Capsid Inhibitors as Antiretroviral Agents.
    Thenin-Houssier S; Valente ST
    Curr HIV Res; 2016; 14(3):270-82. PubMed ID: 26957201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry.
    Zhou J; Price AJ; Halambage UD; James LC; Aiken C
    J Virol; 2015 Sep; 89(17):9068-79. PubMed ID: 26109731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HIV-1 capsid protein as a drug target: recent advances and future prospects.
    Domenech R; Neira JL
    Curr Protein Pept Sci; 2013 Dec; 14(8):658-68. PubMed ID: 24106962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV capsid is a tractable target for small molecule therapeutic intervention.
    Blair WS; Pickford C; Irving SL; Brown DG; Anderson M; Bazin R; Cao J; Ciaramella G; Isaacson J; Jackson L; Hunt R; Kjerrstrom A; Nieman JA; Patick AK; Perros M; Scott AD; Whitby K; Wu H; Butler SL
    PLoS Pathog; 2010 Dec; 6(12):e1001220. PubMed ID: 21170360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid.
    Kortagere S; Madani N; Mankowski MK; Schön A; Zentner I; Swaminathan G; Princiotto A; Anthony K; Oza A; Sierra LJ; Passic SR; Wang X; Jones DM; Stavale E; Krebs FC; Martín-García J; Freire E; Ptak RG; Sodroski J; Cocklin S; Smith AB
    J Virol; 2012 Aug; 86(16):8472-81. PubMed ID: 22647699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.
    Urano E; Ablan SD; Mandt R; Pauly GT; Sigano DM; Schneider JP; Martin DE; Nitz TJ; Wild CT; Freed EO
    Antimicrob Agents Chemother; 2016 Jan; 60(1):190-7. PubMed ID: 26482309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.